MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2012

Dec 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNTA PHARMACEUTICALS CORP (SNTA)
CIK: 0001157601
Period of Report: 2012-12-12

Reporting Person: Gollust Keith R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-12	Common Stock	A	75000	$8.60	Acquired	2673383	Indirect
2012-12-12	Common Stock	A	175000	$8.60	Acquired	175000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	202005	Direct

Footnotes

F1: The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.